4-isothioureidobutyronitrile
- Generic Name
- 4-isothioureidobutyronitrile
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C5H9N3S
- CAS Number
- 500863-50-3
- Unique Ingredient Identifier
- C3059TG1KN
- Background
Thioureidobutyronitrile has been used in trials studying the treatment of Solid Tumors and Ovarian cancer.
- Associated Conditions
- -
- Associated Therapies
- -
A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer
- First Posted Date
- 2017-02-03
- Last Posted Date
- 2018-12-27
- Lead Sponsor
- Innovation Pharmaceuticals, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT03042702
- Locations
- 🇺🇸
Cancer Research, Dallas, Texas, United States
A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
- First Posted Date
- 2012-08-14
- Last Posted Date
- 2016-02-24
- Lead Sponsor
- Cellceutix Corporation
- Target Recruit Count
- 48
- Registration Number
- NCT01664000
- Locations
- 🇺🇸
Dana-Farber / Beth Israel Deaconess Medical Center / Harvard Cancer Center, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath